© Copyright 2020 Emergpharma

January 27, 2016

Top Pharmaceuticals are losing the battle in Emerging Markets and are generating an important slow-down effect in the market. Between 2012 to 2014 many big pharmaceuticals achieved their goal to bring at least 30% of revenues from the so called Pharmergings but, accord...

January 25, 2016

Pfizer, Novartis, MSD, Sanofi and Roche were top 5 big companies in Thailand by revenues in USD. While Novartis grew 15% thanks to its generics division and MSD had also a slight sales increase driven by its diabetes franchise, the rest experienced sales reduction in t...

January 22, 2016

One of the key questions our customers are always asking is which market should be addressed first in the ASEAN Region. Although many issues should be considered together, as this is clearly a multifactorial decision, in most cases product expected prices are used as k...

January 20, 2016

 

 

In 2014 so called Pharmergings (Pharmaceutical Emerging Markets) grew, for first time in a decade, less than the Pharmaceutical Market average. According to IMS data, growth was 5.8% in emergings while the average was 6.4% and 6.6% in developed markets (US, Japan, WE...

Please reload

Featured Posts

Top Pharmaceuticals are losing the battle in Emerging Markets and are generating an important slow-down effect in the market. Between 2012 to 2014 man...

Succeeding in Pharmaceutical Emerging Markets requires a different evaluation of Leadership Capabilities

January 27, 2016

1/4
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • LinkedIn Social Icon
  • Google+ Social Icon
  • Instagram Social Icon